Northwestern postdoctoral scholar Rogan Grant has been selected as a 2024 Schmidt Science Fellow, a program that sponsors promising, emerging scientists with postdoctoral placement in internationally renowned labs and promoting an intersectional approach to addressing global challenges.
Postmenopausal women who took calcium and vitamin D supplements demonstrated reduced cancer mortality but increased cardiovascular mortality after a 20-year follow-up period, according to post-hoc analysis results published in Annals of Internal Medicine.
A multi-institutional team of investigators has discovered that targeting a specific protein interaction within immunosuppressive breast cancer cells may increase antitumor immune responses, according to findings published in the Journal of Clinical Investigation.
Abby Citterman, ’24 MPO, a recent graduate of Northwestern’s Master of Prosthetics & Orthotics program, was awarded the American Academy of Orthotists and Prosthetists Women in O&P Research Award at their 50th annual meeting in Chicago.
A team of Northwestern Medicine investigators has discovered novel DNA methylation patterns in the blood of patients with Parkinson’s disease, findings that demonstrate the potential for using DNA methylation as a biomarker to identify the disease.
A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.
Feinberg investigators have been selected to lead a $15 million American Heart Association research initiative studying the role of inflammation in heart disease.
More than 450 alumni and guests returned to Feinberg on April 18, 19 and 20 to reconnect with former classmates, learn about the medical school’s latest developments and achievements, and reminisce about their medical school experiences.
Feinberg recently hosted a “Second Look” event, providing 150 accepted students with an opportunity to learn more about the medical school’s campus, health equity and inclusion efforts, curriculum and community.
Women with breast cancer who carried the BRCA1 breast cancer mutation and who were enrolled in an MRI surveillance program saw an 80 percent reduction in breast cancer mortality compared to those who did not undergo MRI surveillance, according to findings published in JAMA Oncology.
